X-group (possible homology)

3070 N0 domain in phage tail proteins and secretins-like

Ligands and drugs

1,293
Member domains
135
with ligand contacts (≤ 4 Å)
10.4% of members
95
with DrugDomain annotations
7.3% of members
44
with a DrugBank compound
3.4% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

21
Proteins with classified ligands
7
Superclasses bound (of 23)
7.0
Superclasses per 20 proteins
narrower than 61% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds1010.20.98×q = 1.00
Nucleosides, nucleotides, and analogues05.70q = 4.9e-3
Phenylpropanoids and polyketides20.44.64×not tested
Organic acids and derivatives63.21.87×not tested
Lipids and lipid-like molecules32.31.30×not tested
Organoheterocyclic compounds23.20.63×not tested
Homogeneous non-metal compounds24.50.45×not tested
Organic oxygen compounds14.10.24×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03574FCIFerricrocin-iron4
DB00115CNCCyanocobalamin3
DB08217MTNS-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate2
DB09459TLAL-tartaric acid2
DB18267HEMFerroheme2
DB01747HWSCoprogen1
DB02626PFCPhenylferricrocin-iron1
DB02724ALBDelta-2-Albomycin A11
DB04220RIFCGP 48321

Most frequently bound compounds

PDB ligandNameDomains in contact
CUmetalCOPPER (II) ION12
AGmetalSILVER ION10
PVE(1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]-8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2-A]QUINOLIN-11-IUM10
FEmetalFE (III) ION9
KmetalPOTASSIUM ION7
CLCHLORIDE ION6
NAmetalSODIUM ION6
FCIFERRICROCIN-IRON4
ZNmetalZINC ION4
0UEFerrioxamine B3
188PYOCHELIN FE(III)3
CNCCYANOCOBALAMIN3
FV8(4~{S},5~{R})-2-[2,3-bis(oxidanyl)phenyl]-~{N}-[2-(1~{H}-imidazol-4-yl)ethyl]-5-methyl-~{N}-oxidanyl-4,5-dihydro-1,3-oxazole-4-carboxamide3
HEMPROTOPORPHYRIN IX CONTAINING FE3
A1H492-(2-hydroxyphenyl)-1,3-thiazole-4-carboxylic acid2
A1IG8Pyochelin Fe(III) isomer2
A1IJR~{N}-[(~{E},5~{S})-6-[2-[2-(2-azanylethoxy)ethoxy]ethylamino]-5-[[2-(2-hydroxyphenyl)-1,3-thiazol-4-yl]carbonylamino]-6-oxidanylidene-hex-2-enyl]-2-(2-hydroxyphenyl)-1,3-thiazole-4-carboxamide2
CAmetalCALCIUM ION2
CU1metalCOPPER (I) ION2
EFEENANTIO-PYOCHELIN FE(III)2